Therefore, melanoma tumour cells are not dependent on MCL1 for survival per se; rather they are dependent on MCL1, to a far greater extent than the other pro-survivals, when the ERK1/2 pathway is inhibited. The gene discussed is MAPK3; the disease is melanoma.